The objectives of the study are to; (1) estimate the change in disease -related cognitive decline over 1 year on a battery of cognitive tests administered to participants with early-stage symptomatic Behavioral Variant Frontotemporal Dementia (bvFTD) phenotypic variant; (2) identify the cognitive test or brief battery of cognitive tests which are the most sensitive to detect bvFTD progression; (3) determine the optimal schedule of administration of cognitive tests to detect bvFTD progression; (4) evaluate the relationship between cognitive tests and measures of behavior, function, caregiver's burden, quality of life (QOL); and (5) obtain blood samples for genetic and exploratory biomarkers correlations.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Annualized rate of change in International Shopping List Test (ISLT) - Immediate Recall
Timeframe: Up to 12 Months
Annualized rate of change in Detection Test
Timeframe: Up to 12 Months
Annualized rate of change in Identification Test
Timeframe: Up to 12 Months
Annualized rate of change in One Back Test
Timeframe: Up to 12 Months
Annualized rate of change in Groton Maze Learning Test
Timeframe: Up to 12 Months
Annualized rate of change in ISLT - Delayed Recall
Timeframe: Up to 12 Months
Annualized rate of change in Social Emotional Cognition Test (SECT)
Timeframe: Up to 12 Months
Annualized rate of change in Letter Fluency
Timeframe: Up to 12 Months
Annualized rate of change in Category Fluency
Timeframe: Up to 12 Months
Annualized rate of change in Digit Symbol Coding (DSC)
Timeframe: Up to 12 Months
Annualized rate of change in Letter Number Sequencing (LNS)
Timeframe: Up to 12 Months
Annualized rate of change in Mini Mental State Examination (MMSE)
Timeframe: Up to 12 Months
Change from Day 1 in International Shopping List Test (ISLT) - Immediate Recall
Timeframe: Up to 12 Months
Change from Day 1 in Detection Test
Timeframe: Up to 12 Months
Change from Day 1 in Identification Test
Timeframe: Up to 12 Months
Change from Day 1 in One Back Test
Timeframe: Up to 12 Months
Change from Day 1 in Groton Maze Learning Test
Timeframe: Up to 12 Months
Change from Day 1 in ISLT- Delayed Recall
Timeframe: Up to 12 Months
Change from Day 1 in SECT
Timeframe: Up to 12 Months
Change from Day 1 in Letter Fluency
Timeframe: Up to 12 Months
Change from Day 1 in Category Fluency
Timeframe: Up to 12 Months
Change from Day 1 in DSC
Timeframe: Up to 12 Months
Change from Day 1 in LNS
Timeframe: Up to 12 Months
Change from Day 1 in MMSE
Timeframe: Up to 12 months
Actual values from Day 1 in Neurophsychic Inventory (NPI)
Timeframe: Up to 12 Months
Change from Day 1 in NPI
Timeframe: Up to 12 Months
Actual values from Day 1 in Neurophsychic Inventory Questionnaire (NPI-Q)
Timeframe: Up to 12 Months
Change from Day 1 in NPI-Q
Timeframe: Up to 12 Months
Actual values from Day 1 in Revised Self-Monitoring Scale
Timeframe: Up to 12 Months
Change from Day 1 in Revised Self-Monitoring Scale
Timeframe: Up to 12 Months
Actual values from Day 1 in Apathy Inventory
Timeframe: Up to 12 Months
Change from Day 1 in Apathy Inventory
Timeframe: Up to 12 Months
Actual values from Day 1 in Family Accommodation Scale for Obsessive Compulsive Disorder - Self Rated (FAS-SR)
Timeframe: Up to 12 Months
Change from Day 1 in FAS-SR
Timeframe: Up to 12 Months
Actual values from Day 1 in Behavior Rating Scale
Timeframe: Up to 12 Months
Change from Day 1 in Behavior Rating Scale
Timeframe: Up to 12 Months
Actual values from Day 1 in Functional Activities Questionnaire (FAQ)
Timeframe: Up to 12 Months
Change from Day 1 in FAQ
Timeframe: Up to 12 Months
Actual values from Day 1 in Clinical Global Impression of Change (CGIC)
Timeframe: Up to 12 Months
Change from Day 1 in CGIC
Timeframe: Up to 12 Months
Actual values from Day 1 in Clinical Dementia Rating-Frontotemporal Lobar Degeneration (CDR-FTLD)
Timeframe: Up to 12 Months
Change from Day 1 in CDR-FTLD
Timeframe: Up to 12 Months
Actual values from Day 1 in Unified Parkinson's Disease Rating Scale (UPDRS) Part III
Timeframe: Up to 12 Months
Change from Day 1 in UPDRS Part III
Timeframe: Up to 12 Months
Actual values from Day 1 of caregiver's Quality of Life (QOL) in Zarit Caregiver Burden Interview
Timeframe: Up to 12 Months
Change from Day 1 of caregiver's QOL in Zarit Caregiver Burden Interview
Timeframe: Up to 12 Months
Actual values from Day 1 of QOL in Geriatric Depression Scale- Short Form (GDS-SF)
Timeframe: Up to 12 Months
Change from Day 1 of QOL in GDS-SF
Timeframe: Up to 12 Months
Actual values from Day 1 of caregiver's QOL in Caregiver Assessment Measure
Timeframe: Up to 12 Months
Change from Day 1 of caregiver's QOL in Caregiver Assessment Measure
Timeframe: Up to 12 Months
Actual values from Day 1 of QOL in Quality of Life in Neurological Disorders (NeuroQOL)
Timeframe: Up to 12 Months
Change from Day 1 of QOL in Quality of Life in NeuroQOL
Timeframe: Up to 12 Months
Actual values from Day 1 of QOL in EuroOol 5 Dimensions Questionnaire (EQ-5D)
Timeframe: Up to 12 Months
Change from Day 1 of QOL in EQ-5D
Timeframe: Up to 12 Months
Actual values from Day 1 of QOL in Affect and Activity Indicators of QOL (AAIQOL)
Timeframe: Up to 12 Months
Change from Day 1 of QOL in AAIQOL
Timeframe: Up to 12 Months
Actual values from Day 1 for exploratory biomarkers
Timeframe: Baseline, Month 12
Change from Day 1 for exploratory blood biomarkers
Timeframe: Baseline, Month 12
bvFTD genetic mutations identification in whole blood samples
Timeframe: Baseline, Month 12
Potential identification of genetic biomarkers associated with bvFTD from DNA/RNA in whole blood samples
Timeframe: Baseline, Month 12
Actual values at Day 1 in Clinical Global Impression of Severity (CGIS)
Timeframe: Day 1